Cargando…
Hedgehog Signaling in Myeloid Malignancies
SIMPLE SUMMARY: The Hedgehog signaling pathway is aberrantly activated in many myeloid malignancies, and pathway inhibition is clinically beneficial in specific patients with acute myeloid leukemia. However, even with the approval of these agents, the role of Hedgehog signaling in other myeloid diso...
Autores principales: | Abraham, Ajay, Matsui, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507617/ https://www.ncbi.nlm.nih.gov/pubmed/34638372 http://dx.doi.org/10.3390/cancers13194888 |
Ejemplares similares
-
Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015) -
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
por: Tibes, Raoul, et al.
Publicado: (2014) -
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017) -
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
por: Vaghjiani, Vijesh G., et al.
Publicado: (2023) -
Hedgehog pathway as a drug target: Smoothened inhibitors in development
por: Lin, Tara L, et al.
Publicado: (2012)